Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Outcomes and risk factors for survival of lung transplantation after allogeneic HSCT

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Juan Montoro Gomez; Saskia Bos

Management of passage from pediatric to adult age (transiting) in pediatric EBMT centers

Closed Survey/Study

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Maura Faraci; Claire Horgan

Graft-versus-Host Disease after donor-derived chimeric antigen receptor T-cell infusion post allogeneic HSCT

Retrospective Studies

Transplant Complications Working Party (TCWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Guillermo Ortí

Secondary autoimmune and inflammatory diseases (sec.AIID) post allogeneic HSCT

Retrospective Studies

Transplant Complications Working Party (TCWP)

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Arsene Mekinian

Graft rejection in haploidentical HSCT: survey of subsequent therapeutic options

Closed Survey/Study

Transplant Complications Working Party (TCWP)

Type of treatment

Allogeneic - Haploidentical

Principal investigator

Nadira Durakovic

The impact of blood group disparities on the outcomes of allogeneic stem cell transplantation in the modern era

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Role of HLA Evolutionary Divergence in Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Association between HLA evolutionary divergence and leukemia relapse after allogeneic SCT from 10/10 HLA matched related/unrelated donor

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Outcome of allogeneic stem cell transplantation in patients with psychiatric disorders

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Outcome of patients with Intermediate risk Acute Myelogenous Leukemia in first remission and no detectable residual disease (MRD negative) transplanted with a haploidentical donor versus autografted

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type of treatment

Principal investigator

Norbert-Claude GORIN

Comparison of outcomes after unrelated double-unit cord blood and haploidentical peripheral blood stem cell transplantation in adults with acute myeloid leukemia, a study on behalf of Eurocord and ALWP-EBMT

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type of treatment

Allogeneic - Haploidentical

Principal investigator

Annalisa Ruggeri

The role of measurable residual disease (MRD) at the time of allogeneic stem cell transplantation in patients with AML in CR transplanted from unrelated donors with Post transplant cyclophosphamide

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type of treatment

Principal investigator